Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0012872 (
DNA marker
)
929
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The gene responsible for multiple endocrine neoplasia type 2A (MEN2A) has recently been assigned to the pericentromeric region of chromosome 10 in European Caucasian kindreds by linkage analysis using a
DNA marker
,
interstitial retinol-binding protein 3
(
RBP3
). We have found tight linkage between the MEN2A and
RBP3
loci in Japanese MEN2A kindreds. The maximum lod score is 5.19 at a recombination fraction of 0.00. This result suggests that mutation of a certain gene close to
RBP3
is responsible for MEN2A irrespective of ethnic backgrounds.
...
PMID:Close linkage of MEN2A with RBP3 locus in Japanese kindreds. 256 78
Multiple endocrine neoplasis type 2A (MEN2A) is one of several kinds of cancers that appear to be inherited in an autosomally dominant fashion. We have assigned the MEN2A locus to chromosome 10 by linkage with a new
DNA marker
(D10S5). The linkage led us to investigate other chromosome 10 markers and demonstrate linkage between the disease locus and the
interstitial retinol-binding protein
(
IRBP
) gene. The D10S5 locus was sublocalized to 10q21.1 by hybridization in situ and the
IRBP
gene to p11.2----q11.2 with a secondary site at q24----q25. The linkages were established using 292 members of five families, three different restriction fragment length polymorphisms (RFLPs) at D10S5 and two RFLPs recognized by the
IRBP
probe. The recombination frequencies from pairwise linkage analysis between the disease and two marker loci D10S5 and
IRBP
were 0.19 and 0.11, with maximum lod scores of 3.6 and 8.0 respectively. Ordering of the three loci by multipoint analysis placed the
IRBP
gene approximately midway between the disease and D10S5 loci.
...
PMID:Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. 288 18